Kineret

Anakinra, the active ingredient in Kineret, is a Interleukin-1 receptor antagonist presented as a 100 mg/mL solution for injection for subcutaneous use. It treats rheumatoid arthritis and several autoinflammatory conditions in adults and children.

GNH USA supplies Kineret as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Kineret is an Interleukin‑1 receptor antagonist used in a range of inflammatory and autoinflammatory diseases. - Rheumatoid arthritis: reduces signs and symptoms of disease activity. - Cryopyrin‑Associated Periodic Syndromes (CAPS): controls recurrent fever and systemic inflammation. - Neonatal‑onset multisystem inflammatory disease (NOMID): mitigates chronic inflammatory manifestations. - Systemic juvenile idiopathic arthritis: improves joint function and reduces systemic features. - Adult‑onset Still's disease: alleviates fever, rash and joint pain. - Acute gout flares: shortens duration and severity of attacks.

Kineret may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Injection‑site reactions such as redness, swelling or pain. - Headache. - Nausea. - Upper respiratory tract infection. - Dizziness. - Arthralgia.

Serious or Rare Side Effects: - Neutropenia or other significant blood‑count abnormalities. - Serious infections, including sepsis. - Anaphylactic or severe allergic reactions. - Elevated liver enzymes. - Rare malignancies reported in long‑term use.

Before initiating Kineret, clinicians should evaluate several safety considerations. - Pregnancy: Category B – use only when the potential benefit justifies the potential risk to the fetus. - Infection risk: screen for active infections and monitor for new signs during therapy. - Neutropenia: obtain baseline and periodic complete blood counts. - Live vaccines: avoid administration while on treatment. - Renal impairment: dose adjustment may be required in severe cases. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Kineret can interact with other agents that affect immune function.

Major Interactions (Avoid): - Live vaccines: may cause severe infection. - Concurrent use of other biologic immunosuppressants (e.g., TNF inhibitors): heightened infection risk. - Cytotoxic chemotherapy: increased immunosuppression.

Moderate Interactions (Monitor Closely): - Systemic corticosteroids: additive immunosuppressive effect. - Conventional disease‑modifying antirheumatic drugs (e.g., methotrexate, azathioprine): monitor for infection. - Antibiotics: adjust therapy if neutropenia develops.